Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 421 AL 435

A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits

Zhou Y, Su T, Yuan M, Li WL, Zhou Y, Kou JX, Chang JS, Liu D, Chen L, Zhan K, Zhu LQ.

J Alzheimers Dis. 2025 Oct;107(4):1325-1339. doi: 10.1177/13872877251372587. Epub 2025 Sep 11.

Discovery of natural compounds and their derivatives against neuroinflammation: Pharmacological mechanisms and structure-activity relationship

Xin X, Zong T, Hu Z, Jin L, Zhou W, Sun J, Li G.

Bioorg Chem. 2025 Oct;165:108934. doi: 10.1016/j.bioorg.2025.108934. Epub 2025 Aug 30.

Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives

Hroudová J, Fišar Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Oct 2;142:111491. doi: 10.1016/j.pnpbp.2025.111491. Epub 2025 Sep 9.

Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer's disease

Francis E, Paylor S, Van C, Mathews B, Sobhanian MJ, Mansour DZ, Hennawi G, Brandt NJ.

Expert Rev Clin Pharmacol. 2025 Dec;18(12):1063-1078. doi: 10.1080/17512433.2025.2556122. Epub 2025 Sep 22.

Navigation Between Alzheimer's Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology-Genetics and Neuroinflammation

Bowirrat A, Pinhasov A, Bowirrat A, Badgaiyan R.

Int J Mol Sci. 2025 Aug 26;26(17):8253. doi: 10.3390/ijms26178253.

Mast Cell Immunometabolism in Type 2 Diabetes and Alzheimer's Disease

Caslin HL, Kapadia M, Clemons TA.

J Cell Physiol. 2025 Sep;240(9):e70091. doi: 10.1002/jcp.70091.

Neutrophils and NETosis in Alzheimer's disease: Unraveling pathogenic mechanisms and novel therapeutic targets

Chavoshinezhad S, Beirami E, Izadpanah E.

Biomed Pharmacother. 2025 Nov;192:118568. doi: 10.1016/j.biopha.2025.118568. Epub 2025 Sep 18.

Animal models of tau propagation in Alzheimer's disease

Masuda-Suzukake M, Shimonaka S, Nonaka T, Hasegawa M.

Neurosci Res. 2025 Nov;220:104960. doi: 10.1016/j.neures.2025.104960. Epub 2025 Sep 23.

A decade progress in the phenotyping of App(NL-G-F) knock-in mouse model of Alzheimer's disease

Manabe T, Saito T.

Neurosci Res. 2025 Nov;220:104959. doi: 10.1016/j.neures.2025.104959. Epub 2025 Sep 23.

The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease

Moorthy H, Sain S, Padhi D, Govindaraju T.

J Med Chem. 2025 Oct 9;68(19):19828-19845. doi: 10.1021/acs.jmedchem.5c00917. Epub 2025 Sep 26.

Testosterone as a mediator of APOE4-linked sex differences in Alzheimer's disease

Shi Z, Wu L, Zhang C, Zeng X, Yao G, He X, Hu J, Xie T, He L.

Int Immunopharmacol. 2025 Dec 3;166:115588. doi: 10.1016/j.intimp.2025.115588. Epub 2025 Sep 28.

Microglia networks within the tapestry of alzheimer's disease through spatial transcriptomics

Zhou Y, Glass CK.

Mol Neurodegener. 2025 Sep 29;20(1):102. doi: 10.1186/s13024-025-00897-y.

Astrocytes as Metabolic Sensors Orchestrating Energy-Driven Brain Vulnerability in Alzheimer's Disease

Sánchez de Muniain L, Escalada P, Ramírez MJ, Solas M.

J Neurochem. 2025 Oct;169(10):e70252. doi: 10.1111/jnc.70252.

Proteostasis and Neuroinflammation in Alzheimer's Disease

Potokiri A, Wang H.

J Integr Neurosci. 2025 Sep 18;24(9):39826. doi: 10.31083/JIN39826.

Alzheimer's Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Ivanova AV, Kutuzova AD, Kuzmichev IA, Abakumov MA.

Int J Mol Sci. 2025 Sep 26;26(19):9444. doi: 10.3390/ijms26199444.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias